Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
Camilla Pecoraro, Daniela Carbone, Fabio Scianò, Francesca Terrana, Geng Xu, Cecilia Bergonzini, Margot S. F. Roeten, Stella Cascioferro, Girolamo Cirrincione, Patrizia Diana, Elisa Giovannetti, Barbara Parrino
This study identifies compound 10l as a potent FAK inhibitor with antitumor activity and safety in pancreatic cancer models.
Journal of drug targeting · Jul 27, 2024Peer-reviewedCancer Biology